Stocks
Vanda Pharmaceuticals (VNDA) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 4 774% | 3 096% | 13 653% | 12 632% | 20 058% | 14 921% | |||
| Changes by years, y/y, % | +4 602pp | -1 678pp | +10 557pp | -1 021pp | +7 426pp | +159.1% | |||
Vanda Pharmaceuticals. R&D/CAPEX, %
Vanda Pharmaceuticals. R&D/CAPEX, changes, pp
Vanda Pharmaceuticals (VNDA) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| R&D/CAPEX, % | 69 167% | 9 620% | 302 200% | 15 427% | 10 420% | 14 921% | ||
| Changes by years, y/y, % | +52 371pp | +2 603pp | +264 480pp | -14 840pp | -58 747pp | |||
| Changes by quarters, q/q, % | +38 899pp | -59 547pp | +292 580pp | -286 773pp | -5 007pp | |||
